Results 71 to 80 of about 1,148 (137)

Leveraging Blockchain and Smart Contracts to Combat Greenwashing in Sustainable Development

Sustainable Development, Volume 33, Issue 4, Page 5874-5889, August 2025.
ABSTRACT Blockchain technology, when combined with smart contracts, enables buyers to distinguish between greenwashed and genuinely eco‐friendly products. The presence of counterfeit items can severely impact supply chains by diminishing brand value, eroding consumer confidence, and undermining market trust.
Ragnhild Silkoset, Arne Nygaard
wiley   +1 more source

Development of an agent-based model to assess the impact of substandard and falsified anti-malarials: Uganda case study

Malaria Journal, 2019
Background Global efforts to address the burden of malaria have stagnated in recent years with malaria cases beginning to rise. Substandard and falsified anti-malarial treatments contribute to this stagnation.
Sachiko Ozawa, Daniel R. Evans, Colleen R. Higgins, Sarah K. Laing, Phyllis Awor   +4 more
doaj   +1 more source

Evaluation of community pharmacists’ readiness to implement the Falsified Medicines Directive (Directive 2011/62/EC): an English cross-sectional survey with geospatial analysis

BMJ Open, 2020
Objectives To evaluate the readiness to implement the Falsified Medicines Directive (FMD) by community pharmacies in England. Eight secondary objectives were assessed.Setting Community/retail pharmacies.Participants We invited pharmacists from 501 ...
Ravina Barrett
doaj   +1 more source

Financial crimes in Africa and economic growth: Implications for achieving sustainable development goals (SDGs)

Journal of Economic Surveys, Volume 39, Issue 3, Page 1212-1251, July 2025.
Abstract The current review systematically synthesizes existing literature to provide a comprehensive overview of the nature of financial crimes in Africa and their impact on economic growth. We adopted the PRISMA protocol to identify 128 papers from the Scopus database, which were analyzed using MS Excel, VOSviewer, and R‐packages (Bibliometrix).
Kingsley K. Arthur, Simplice A. Asongu, Peter Darko, Marvin O. Ansah, Sampson Adom, Omega Hlortu   +5 more
wiley   +1 more source

Fighting the fakes: tackling substandard and falsified medicines

Nature Reviews Disease Primers, 2022
Pyzik, Oksana Zirka, Abubakar, Ibrahim
openaire   +3 more sources

The Substandard and falsified medicines in the Democratic Republic of the Congo: Situational analysis and future perspectives

Orapuh Journal
Introduction The circulation of counterfeit medicines in the Democratic Republic of the Congo (DRC) and elsewhere is driven by several factors, including regulatory weaknesses, inadequate inspections, and porous borders.
Michel NTAMBWE NGOYI, Donatien KABAMB KABEYA, Didi Mana Kialengila, Roland Marini Djang’ieng’a, Jéremie Mbinze Kindenge   +4 more
doaj   +1 more source

Global landscape assessment of screening technologies for medicine quality assurance: stakeholder perceptions and practices from ten countries

Globalization and Health, 2018
Background The spread of substandard and falsified (SF) medical products constitutes a growing global public health concern. Some countries use portable, handheld screening technologies (STs) in the field to accelerate detection of SF medicines and ...
Lukas Roth, Ameena Nalim, Beth Turesson, Laura Krech   +3 more
doaj   +1 more source

Prevention, Detection and Response to incidences of substandard and falsified medical products in the Member States of the Southern African Development Community

Journal of Pharmaceutical Policy and Practice, 2020
Background Medical products are an integral and pivotal part of health care delivery. They need to be available, affordable and quality-assured. The SADC region is prone to threats arising from the availability and use of substandard and falsified (SF ...
Stanislav Kniazkov, Sakhile Dube-Mwedzi, Jean-Baptiste Nikiema   +2 more
doaj   +1 more source

Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems

Globalization and Health, 2018
Access to quality-assured medical products improves health and save lives. However, one third of the world’s population lacks timely access to quality-assured medicines while estimates indicate that at least 10% of medicine in low- and middle-income ...
Lukas Roth, Daniel Bempong, Joseph B. Babigumira, Shabir Banoo, Emer Cooke, David Jeffreys, Lombe Kasonde, Hubert G. M. Leufkens, John C. W. Lim, Murray Lumpkin, Gugu Mahlangu, Rosanna W. Peeling, Helen Rees, Margareth Ndomondo-Sigonda, Andy Stergachis, Mike Ward, Jude Nwokike   +16 more
doaj   +1 more source

Patients Access to Medicines – A Critical Review of the Healthcare System in Kenya

Risk Management and Healthcare Policy, 2022
Anthony Martin Toroitich,1,2 Louise Dunford,3 Rachel Armitage,4 Sangeeta Tanna2 1Trade Affairs Department, Pharmacy and Poisons Board, Nairobi, Kenya; 2Leicester School of Pharmacy, De Montfort University, Leicester, UK; 3Leicester School of Allied ...
Toroitich AM, Dunford L, Armitage R, Tanna S   +3 more
doaj